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• Her profound hypothyroidism appears to have contributed to her 
hypercalcemia.  
• After correcting her hypothyroidism, her hypercalcemia resolved 
and has not recurred.  
• Her renal function also improved with correction of the 
hypercalcemia, with a current creatinine of 1.6.   
 
Discussion 
• This case presents an important question: Can myxedema cause 
hypercalcemia?  
• In a study published in 1962, investigators studied the effects of 
hypothyroidism on calcium balance in rats, based on a patient 
with similar findings.  
• Their observations showed that “thyroid insufficiency may be 
accompanied by the propensity toward the development of 
hypercalcemia upon ingestion of large amounts of calcium.”  
• Although our patient was not known to be ingesting excessive 
amounts of calcium, there appears to be no other explanation for 
her hypercalcemia and its resolution other than profound 
hypothyroidism and its successful treatment.  
• We suggest that, although apparently rare, the differential 
diagnosis of hypercalcemia should include profound 
hypothyroidism.  
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Introduction 
• Hypercalcemia is a relatively common clinical problem occurring 
when there is increased bone resorption, excessive 
gastrointestinal absorption, or decreased renal excretion of 
calcium.  
• The most common causes of hypercalcemia are primary 
hyperparathyroidism and malignancy, accounting for 90% of all 
cases. 
• Ten percent of cases are caused by other conditions. 
 
Case Presentation 
• A 45-year-old female with no significant past medical history, 
presented to her primary care physician with fatigue, falling, 
decreased appetite, and weakness.  
• Labs showed a serum creatinine of 4 mg/dL, a serum calcium of 15 
mg/dL, and a TSH level of 177 mI/L.  No metabolic alkalosis was 
present. 
• She was admitted to the hospital and treated with IV fluids, 
calcitonin, and levothyroxine.  
• Her PTH and PTH-related peptide were low; further workup was 
directed towards evaluation of a systemic or neoplastic process as 
a cause of hypercalcemia, which was causing the acute renal 
failure.  
• CT scans of the chest, abdomen, and pelvis failed to reveal any 
evidence of neoplasm, lymphoma, or renal abnormalities.  
• Urine and serum studies were obtained to assess for multiple 
myeloma, revealing a polyclonal gammopathy of uncertain 
significance.  
• Bone marrow aspirate did not reveal evidence of malignancy.  
• Her condition improved and she was able to be switched from IV 
to oral levothyroxine.  
